(Q44673373)

5 December 2017

0 references

In and out, good and bad news, of generalizability of SWOG treatment trial results (English)

1 reference

5 December 2017

Archie Bleyer

1

1 reference

5 December 2017

language of work or name

English

0 references

publication date

13 March 2014

1 reference

Journal of the National Cancer Institute

5 December 2017

published in

1 reference

5 December 2017

volume

106

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

dju027

1 reference

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Tribulations of a prostate cancer trial – lessons learned from TOAD, a Cancer Council Victoria and Transtasman Radiation Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Review of health-related quality of life data in multiple myeloma patients treated with novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Benefit and harms of new anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Endpoints for clinical trials and revised assessment in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU027

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJU027

1 reference

5 December 2017

1 reference